MONTPELLIER, France, Nov. 3, 2015 (GLOBE NEWSWIRE) -- MEDTECH (Euronext, FR0010892950 – ROSA) ("Medtech" or the "Company"), a company specialized in designing, developing and marketing innovative surgical assistance robots, announced today that it has obtained a commitment from Ally Bridge Group ("ABG"), a global healthcare-focused investment group, for a purchase of convertible notes maturing in 2020, otherwise known as OCABSA 2020 (the "Convertible Notes"), and warrants to purchase shares of its common stock (the "Warrants", and together with the Convertibles Notes, the "Securities"). Gross proceeds to the Company are expected to be $15 million, prior to the payment of placement...
↧